Explore surgeries / Rotator Cuff Repair Explained
New research, guidelines and FDA decisions, each with a note on what it might change in a conversation with your surgeon, how certain it is, and links to the original sources.
How we choose news. Nothing here is sponsored. Mentioning a product isn't an endorsement, and an FDA clearance means a device was found substantially equivalent to existing ones, not proven better. Updated November 2026.
The AAOS Shoulder & Elbow Registry 2026 report found subacromial decompression was performed in 39.5% of arthroscopic rotator cuff repairs, continuing a decline.
What this could change in a conversation with your surgeon: If acromioplasty is planned, ask why. Current guidance doesn't suggest it routinely for small to medium tears.
Sources: AAOS fact sheet
A randomized trial in high-grade partial-thickness tears compared a bioinductive implant alone with taking down and repairing the tendon. Early recovery was faster with the implant, and tendon healing at 12 months was similar (90% vs 85%).
What this could change in a conversation with your surgeon: For some partial tears, a smaller operation may get you back to daily life sooner. Long-term outcomes were similar.
Sources: Smith+Nephew summary of Wang A, et al. Orthop J Sports Med 2026
In a trial of 126 patients, a repair technique combining the repair with small holes in the bone (to release healing cells) had a lower retear rate than standard single-row repair, with similar function.
What this could change in a conversation with your surgeon: Surgeons are trying several low-cost ways to improve healing. Ask what your surgeon does to help the tendon heal.
Sources: J Shoulder Elbow Surg, doi:10.1016/j.jse.2025.05.030
A systematic review found structural augmentation lowered retear rates, especially with allograft, but did not improve short-term patient-reported outcomes.
What this could change in a conversation with your surgeon: A healed tendon matters long term, but don't expect an augment to make the first months feel different.
Sources: Am J Sports Med (abstract)
Smith+Nephew announced two-year results from a randomized trial: 12.3% retears with the REGENETEN implant added to repair versus 35.1% with standard repair.
What this could change in a conversation with your surgeon: Lower retear rates are promising. These are company-announced results, so ask whether your tear type matches the study.
Sources: MassDevice
The updated guideline has 21 recommendations. It supports bioinductive implants during repair, upgrades evidence for dermal allograft, doesn't support porcine grafts, and found similar results with early or delayed sling removal for small to medium tears.
What this could change in a conversation with your surgeon: This is what many US surgeons will follow. It's useful to know when you discuss options.
Sources: AAOS press release · ODT summary
See news across every procedure on the Informed Surgery news page.